Harbinger Health secures $140m to advance early cancer screening platform
Harbinger Health intends to use the funds to complete the Cancer ORigin Epigenetics-Harbinger Health 10,000-participant clinical trial of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Sep 23
Harbinger Health intends to use the funds to complete the Cancer ORigin Epigenetics-Harbinger Health 10,000-participant clinical trial of…
29 Sep 23
USound’s Achelous UT-P2016 MEMS speaker is ideal for manufacturing MRI-headphones due to the absence of ferromagnetic parts in…
29 Sep 23
It provides critical support to men, aged 40 to 75, and their physicians in making more informed decisions,…
29 Sep 23
The PSCA System is designed for extravascular placement to provide hemodynamic support for chronic heart failure patients without…
29 Sep 23
SPARTA technology to accelerate the development, manufacture and quality control of nanoparticles used for gene therapies, vaccines, and…
28 Sep 23
Together with the ARC-IM Stimulator, patients also received a wireless brain-computer interface (BCI), which enables the delivery of…
28 Sep 23
The medical device company will use the financing to support the US commercialisation of its BioProtect Balloon Implant…
28 Sep 23
Following the approval, the US-based EnCompass Technologies plans to immediately start clinical site start-up activities in patients undergoing…
28 Sep 23
VSP Bolus is designed to deliver 3D-printed, patient-specific, biocompatible boluses, that can increase therapy modulation, cut down on…
28 Sep 23
Company Continues to Build Momentum with Most Recent Portfolio Expansion.